CR Group L.P.

Insider Reports History

Location
Houston, TX
Signature
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG Partners III - Parallel Fund B (Cayman) LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CR Group L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
T2 Biosystems, Inc. 10%+ Owner Common Stock 4,704,729 $740,995 $0.1575 09 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P.
T2 Biosystems, Inc. 10%+ Owner Series B Convertible Preferred Stock 59,703 03 Jul 2023 By CRG Partners III Parallel Fund (B) (Cayman) L.P.
T2 Biosystems, Inc. 10%+ Owner Series B Convertible Preferred Stock 33,595 03 Jul 2023 By CRG Partners III (Cayman) Lev AIV I L.P.
T2 Biosystems, Inc. 10%+ Owner Series A Convertible Preferred Stock 28,036 12 Apr 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P.
Avinger Inc 10%+ Owner Series E Convertible Preferred Stock 733 04 Aug 2023 By CRG Partners III Parallel Fund (B) (Cayman) L.P.
Avinger Inc 10%+ Owner Series E Convertible Preferred Stock 658 04 Aug 2023 By CRG Partners III (Cayman) Lev AIV I L.P.
Avinger Inc 10%+ Owner Series E Convertible Preferred Stock 310 04 Aug 2023 By CRG Partners III L.P.
Avinger Inc 10%+ Owner Series E Convertible Preferred Stock 166 04 Aug 2023 By CRG Partners III ? Parallel Fund (A) L.P.
Avinger Inc 10%+ Owner Series E Convertible Preferred Stock 53 04 Aug 2023 By CRG Partners III (Cayman) Unlev AIV I L.P.
T2 Biosystems, Inc. 10%+ Owner Series A Preferred Stock 0 09 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P.
T2 Biosystems, Inc. 10%+ Owner Series B Preferred Stock 0 09 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P.

Insider Reports Filed by CR Group L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TTOO T2 Biosystems, Inc. 09 May 2024 4 $0 4 10%+ Owner 13 May 2024, 18:19
TTOO T2 Biosystems, Inc. 03 May 2024 5 $0 4 10%+ Owner 07 May 2024, 16:57
TTOO T2 Biosystems, Inc. 12 Apr 2024 6 $0 4 10%+ Owner 16 Apr 2024, 20:35
TTOO T2 Biosystems, Inc. 14 Feb 2024 4 $0 4 10%+ Owner 16 Feb 2024, 17:17
TTOO T2 Biosystems, Inc. 27 Sep 2023 8 -$2,271,957 4 10%+ Owner 29 Sep 2023, 17:30
TTOO T2 Biosystems, Inc. 26 Sep 2023 4 -$1,082,359 4 10%+ Owner 28 Sep 2023, 17:30
TTOO T2 Biosystems, Inc. 25 Sep 2023 4 -$62,500 4 10%+ Owner 27 Sep 2023, 18:53
TTOO T2 Biosystems, Inc. 22 Sep 2023 4 -$1,314,534 4 10%+ Owner 26 Sep 2023, 18:15
TTOO T2 Biosystems, Inc. 21 Sep 2023 4 -$1,904,632 4 10%+ Owner 25 Sep 2023, 21:30
TTOO T2 Biosystems, Inc. 20 Sep 2023 4 -$2,408,302 4 10%+ Owner 22 Sep 2023, 17:15
TTOO T2 Biosystems, Inc. 19 Sep 2023 4 -$3,806,937 4 10%+ Owner 21 Sep 2023, 17:30
/report/000120919123045243-cr-group-l-p-2023-08-04 Avinger Inc 04 Aug 2023 5 $0 4 10%+ Owner 09 Aug 2023, 19:08
/report/000120919123045242-cr-group-l-p-2023-08-04 Avinger Inc 04 Aug 2023 0 $0 3 10%+ Owner 09 Aug 2023, 19:06
TTOO T2 Biosystems, Inc. 03 Jul 2023 2 $0 4/A 10%+ Owner 14 Jul 2023, 18:57
TTOO T2 Biosystems, Inc. 03 Jul 2023 0 $0 3 10%+ Owner 06 Jul 2023, 18:40